Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (241-250 of 999) with videos related to

Pageof 100
Sort By:
Journal of Clinical Lipidology|October 4, 2020
Monocyte phenotyping and management of lipoprotein X syndromeZeqin Lian, Anum Saeed, Xueying Peng, et al.
Obesity (Silver Spring, Md.)|October 2, 2010
Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesityQun Wang, Xiaoyuan D Perrard, Jerry L Perrard, et al.
Cardiovascular Diabetology|July 10, 2013
Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR studyEliot A Brinton, Christie M Ballantyne, Harold E Bays, et al.
Computer Methods in Biomechanics and Biomedical Engineering. Imaging & Visualization|March 6, 2018
Patient-Specific Flow Descriptors and Normalized wall index in Peripheral Artery Disease: a Preliminary StudyJaykrishna Singh, Gerd Brunner, Joel D Morrisett, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|July 27, 2007
Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities StudyA Vigo, B B Duncan, M I Schmidt, et al.
The American Journal of Cardiology|June 21, 2011
Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial)Harold E Bays, Christie M Ballantyne, John J Kastelein, et al.
Circulation|April 1, 1996
Levels of soluble cell adhesion molecules in patients with dyslipidemiaA Hackman, Y Abe, W Insull, et al.
American Journal of Epidemiology|September 13, 2013
Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC StudySeamus P Whelton, Probal Roy, Brad C Astor, et al.
Journal of Clinical Lipidology|February 5, 2011
Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) studyChristie M Ballantyne, Michael H Davidson, James M McKenney, et al.
Clinical Chemistry|April 9, 2020
Associations of Cardiac, Kidney, and Diabetes Biomarkers With Peripheral Neuropathy among Older Adults in the Atherosclerosis Risk in Communities (ARIC) StudyCaitlin W Hicks, Dan Wang, Natalie R Daya, et al.
Pageof 100

Showing results (241-250 of 999) with videos related to

Sort By:
Pageof 100
Journal of Clinical Lipidology|October 4, 2020
Monocyte phenotyping and management of lipoprotein X syndromeZeqin Lian, Anum Saeed, Xueying Peng, et al.
Obesity (Silver Spring, Md.)|October 2, 2010
Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesityQun Wang, Xiaoyuan D Perrard, Jerry L Perrard, et al.
Cardiovascular Diabetology|July 10, 2013
Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR studyEliot A Brinton, Christie M Ballantyne, Harold E Bays, et al.
Computer Methods in Biomechanics and Biomedical Engineering. Imaging & Visualization|March 6, 2018
Patient-Specific Flow Descriptors and Normalized wall index in Peripheral Artery Disease: a Preliminary StudyJaykrishna Singh, Gerd Brunner, Joel D Morrisett, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|July 27, 2007
Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities StudyA Vigo, B B Duncan, M I Schmidt, et al.
The American Journal of Cardiology|June 21, 2011
Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial)Harold E Bays, Christie M Ballantyne, John J Kastelein, et al.
Circulation|April 1, 1996
Levels of soluble cell adhesion molecules in patients with dyslipidemiaA Hackman, Y Abe, W Insull, et al.
American Journal of Epidemiology|September 13, 2013
Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC StudySeamus P Whelton, Probal Roy, Brad C Astor, et al.
Journal of Clinical Lipidology|February 5, 2011
Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) studyChristie M Ballantyne, Michael H Davidson, James M McKenney, et al.
Clinical Chemistry|April 9, 2020
Associations of Cardiac, Kidney, and Diabetes Biomarkers With Peripheral Neuropathy among Older Adults in the Atherosclerosis Risk in Communities (ARIC) StudyCaitlin W Hicks, Dan Wang, Natalie R Daya, et al.
Pageof 100